These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 33643295

  • 1. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.
    Vleeshouwers W, van den Dries K, de Keijzer S, Joosten B, Lidke DS, Cambi A.
    Front Immunol; 2020; 11():613286. PubMed ID: 33643295
    [Abstract] [Full Text] [Related]

  • 2. T cell-intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation.
    Lee J, Aoki T, Thumkeo D, Siriwach R, Yao C, Narumiya S.
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [Abstract] [Full Text] [Related]

  • 3. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW, Wang WS, Zhou Q, Gan XW, Myatt L, Sun K.
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [Abstract] [Full Text] [Related]

  • 4. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E2 Activation in Human Podocytes.
    Mangelsen E, Rothe M, Schulz A, Kourpa A, Panáková D, Kreutz R, Bolbrinker J.
    Cells; 2020 May 19; 9(5):. PubMed ID: 32438662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.
    Samuchiwal SK, Balestrieri B, Raff H, Boyce JA.
    J Biol Chem; 2017 May 19; 292(20):8195-8206. PubMed ID: 28341741
    [Abstract] [Full Text] [Related]

  • 7. The Gαs-protein-mediated pathway may be steadily stimulated by prostanoid EP2 receptors, but not by EP4 receptors.
    Fukushima K, Senoo K, Kurata N, Regan JW, Fujino H.
    FEBS Open Bio; 2022 Apr 19; 12(4):775-783. PubMed ID: 35124898
    [Abstract] [Full Text] [Related]

  • 8. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV, Gavrila A, Nayak AP, Pera T, Liberato JR, Polischak SR, Shah SD, Deshpande DA, Penn RB.
    FASEB J; 2019 Apr 19; 33(4):4780-4789. PubMed ID: 30601680
    [Abstract] [Full Text] [Related]

  • 9. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ, Holtz A, Lopez J, Freund D, Chen A, Wang D, Powell D, Kipper F, Panigrahy D, Dubois RN, Whiting CC, Prasit P, Dubensky TW.
    Cancer Res Commun; 2023 Aug 19; 3(8):1486-1500. PubMed ID: 37559947
    [Abstract] [Full Text] [Related]

  • 10. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
    Hatae N.
    Yakugaku Zasshi; 2003 Oct 19; 123(10):837-43. PubMed ID: 14577329
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection.
    Wan M, Tang X, Rekha RS, Muvva SSVJR, Brighenti S, Agerberth B, Haeggström JZ.
    FASEB J; 2018 May 19; 32(5):2827-2840. PubMed ID: 29401596
    [Abstract] [Full Text] [Related]

  • 12. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
    Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, Suetsugu H, Kazumori H, Cava CF, Kadowaki Y, Fukuda R, Kinoshita Y.
    J Lab Clin Med; 2002 Aug 19; 140(2):92-102. PubMed ID: 12228765
    [Abstract] [Full Text] [Related]

  • 13. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
    Bödder J, Kok LM, Fauerbach JA, Flórez-Grau G, de Vries IJM.
    Int J Mol Sci; 2023 Jan 11; 24(2):. PubMed ID: 36674907
    [Abstract] [Full Text] [Related]

  • 14. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 15. EP2 and EP4 receptor antagonists: Impact on cytokine production and β2 -adrenergic receptor desensitization in human airway smooth muscle.
    Bradbury P, Rumzhum NN, Ammit AJ.
    J Cell Physiol; 2019 Jul 01; 234(7):11070-11077. PubMed ID: 30536718
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C, Zhao R, Vallejo J, Igwe O, Bonewald L, Wetmore L, Brotto M.
    Cell Cycle; 2015 Jul 01; 14(10):1507-16. PubMed ID: 25785867
    [Abstract] [Full Text] [Related]

  • 17. Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses.
    Robb CT, Zhou Y, Felton JM, Zhang B, Goepp M, Jheeta P, Smyth DJ, Duffin R, Vermeren S, Breyer RM, Narumiya S, McSorley HJ, Maizels RM, Schwarze JKJ, Rossi AG, Yao C.
    Allergy; 2023 Mar 01; 78(3):714-730. PubMed ID: 36181709
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K, Iwasaki K, Shitashige M, Ishikawa I.
    J Periodontal Res; 1999 Nov 01; 34(8):478-85. PubMed ID: 10697805
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
    Elberg D, Turman MA, Pullen N, Elberg G.
    Prostaglandins Other Lipid Mediat; 2012 May 01; 98(1-2):11-6. PubMed ID: 22503965
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
    Sokolowska M, Chen LY, Liu Y, Martinez-Anton A, Qi HY, Logun C, Alsaaty S, Park YH, Kastner DL, Chae JJ, Shelhamer JH.
    J Immunol; 2015 Jun 01; 194(11):5472-5487. PubMed ID: 25917098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.